Serum brain-derived neurotrophic factor and glial cell-derived neurotrophic factor in patients with first-episode depression at different ages.

IF 2.9 4区 医学 Q2 PSYCHIATRY
Xianping He, Jingyao Song, He Gao, Zhenyang Li, Xiaochun Wang, Qiaoling Zeng, Yucen Xiao, Jiaxin Feng, Dongdong Zhou, Gaomao Wang
{"title":"Serum brain-derived neurotrophic factor and glial cell-derived neurotrophic factor in patients with first-episode depression at different ages.","authors":"Xianping He,&nbsp;Jingyao Song,&nbsp;He Gao,&nbsp;Zhenyang Li,&nbsp;Xiaochun Wang,&nbsp;Qiaoling Zeng,&nbsp;Yucen Xiao,&nbsp;Jiaxin Feng,&nbsp;Dongdong Zhou,&nbsp;Gaomao Wang","doi":"10.1080/13651501.2022.2107938","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>We investigated the differences in serum brain-derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF) levels and clinical symptoms with first-episode depression at different ages.</p><p><strong>Methods: </strong>Ninety patients (15-60 years old) diagnosed with first-episode depression were enrolled as the study group, and they were divided into early-onset, adult and late-onset groups. The age-matched control groups were healthy volunteers. Serum BDNF and GDNF concentrations were determined by enzyme-linked immunosorbent assay (ELISA). GraphPad Prism 9 was used for t tests, one-way ANOVAs, chi-square tests, and correlation analyses. <i>p</i> < 0.05 indicated significant differences.</p><p><strong>Results: </strong>Serum BDNF and GDNF levels were lower in the whole study group and the three subgroups than in the healthy groups. Illness severity, anxiety and education were higher in the early-onset than late-onset patients. Serum BDNF levels were lower in the adult than late-onset patients. Serum BDNF levels were negatively correlated with patient CGI-SI scores. After the LSD test for multiple comparisons, the results were also significant.</p><p><strong>Conclusions: </strong>Low serum BDNF and GDNF levels may be involved in the pathophysiology of first-episode depression, and there were differences in serum BDNF levels at different ages, verifying that serum BDNF and GDNF could serve as potential biomarkers of depression. KEY POINTSDepression is often conceptualised as a systemic illness with different biological mechanisms, but satisfactory explanations have not been provided thus far.The aim of our study was to investigate differences in serum BDNF and GDNF levels and their relationships with clinical symptoms in patients with first-episode depression at different ages.The potential of the neurotrophic factor hypothesis to advance the diagnosis and treatment of depression will be a very exciting new strategy for future research.</p>","PeriodicalId":14351,"journal":{"name":"International Journal of Psychiatry in Clinical Practice","volume":"27 2","pages":"118-126"},"PeriodicalIF":2.9000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Psychiatry in Clinical Practice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/13651501.2022.2107938","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: We investigated the differences in serum brain-derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF) levels and clinical symptoms with first-episode depression at different ages.

Methods: Ninety patients (15-60 years old) diagnosed with first-episode depression were enrolled as the study group, and they were divided into early-onset, adult and late-onset groups. The age-matched control groups were healthy volunteers. Serum BDNF and GDNF concentrations were determined by enzyme-linked immunosorbent assay (ELISA). GraphPad Prism 9 was used for t tests, one-way ANOVAs, chi-square tests, and correlation analyses. p < 0.05 indicated significant differences.

Results: Serum BDNF and GDNF levels were lower in the whole study group and the three subgroups than in the healthy groups. Illness severity, anxiety and education were higher in the early-onset than late-onset patients. Serum BDNF levels were lower in the adult than late-onset patients. Serum BDNF levels were negatively correlated with patient CGI-SI scores. After the LSD test for multiple comparisons, the results were also significant.

Conclusions: Low serum BDNF and GDNF levels may be involved in the pathophysiology of first-episode depression, and there were differences in serum BDNF levels at different ages, verifying that serum BDNF and GDNF could serve as potential biomarkers of depression. KEY POINTSDepression is often conceptualised as a systemic illness with different biological mechanisms, but satisfactory explanations have not been provided thus far.The aim of our study was to investigate differences in serum BDNF and GDNF levels and their relationships with clinical symptoms in patients with first-episode depression at different ages.The potential of the neurotrophic factor hypothesis to advance the diagnosis and treatment of depression will be a very exciting new strategy for future research.

不同年龄首发抑郁症患者血清脑源性神经营养因子与神经胶质细胞源性神经营养因子的关系。
目的:探讨不同年龄首发抑郁症患者血清脑源性神经营养因子(BDNF)和神经胶质细胞系源性神经营养因子(GDNF)水平及临床症状的差异。方法:将90例确诊为首发抑郁症的患者(15 ~ 60岁)作为研究组,分为早发型组、成年组和晚发型组。年龄匹配的对照组是健康的志愿者。采用酶联免疫吸附试验(ELISA)测定血清BDNF和GDNF浓度。采用GraphPad Prism 9进行t检验、单因素方差分析、卡方检验和相关分析。p结果:整个研究组和三个亚组的血清BDNF和GDNF水平均低于健康组。早发患者的疾病严重程度、焦虑和受教育程度高于晚发患者。成人患者血清BDNF水平低于晚发患者。血清BDNF水平与患者CGI-SI评分呈负相关。经LSD多重比较检验,结果同样显著。结论:血清BDNF和GDNF水平低可能参与首发抑郁症的病理生理过程,且不同年龄段血清BDNF水平存在差异,验证血清BDNF和GDNF可作为抑郁症的潜在生物标志物。抑郁症通常被认为是一种具有不同生物学机制的全身性疾病,但迄今为止还没有令人满意的解释。本研究旨在探讨不同年龄首发抑郁症患者血清BDNF和GDNF水平的差异及其与临床症状的关系。神经营养因子假说在促进抑郁症诊断和治疗方面的潜力将是未来研究的一个非常令人兴奋的新策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.00
自引率
3.30%
发文量
42
审稿时长
>12 weeks
期刊介绍: International Journal of Psychiatry in Clinical Practice provides an international forum for communication among health professionals with clinical, academic and research interests in psychiatry. The journal gives particular emphasis to papers that integrate the findings of academic research into realities of clinical practice. Focus on the practical aspects of managing and treating patients. Essential reading for the busy psychiatrist, trainee and interested physician. Includes original research papers, comprehensive review articles and short communications. Key words: Psychiatry, Neuropsychopharmacology, Mental health, Neuropsychiatry, Clinical Neurophysiology, Psychophysiology, Psychotherapy, Addiction, Schizophrenia, Depression, Bipolar Disorders and Anxiety.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信